Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study: One-year follow-up

European Heart Journal

Volumn 25, Issue 1, 2004, Pages 25-31

  Gurfinkel, Enrique P ^a   Leon De La Fuente, Ricardo ^a   Mendiz, Oscar ^a   Mautner, Branco ^a  

^a Foundation Favaloro   (Argentina)

Author keywords

Cardiovascular disease; Influenza vaccine; Myocardial infarction

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEATH; FOLLOW UP; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOMES RESEARCH; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; ST SEGMENT ELEVATION; STENT;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ARTERY BYPASS; FOLLOW-UP STUDIES; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; STENTS; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0347988302     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ehj.2003.10.018     Document Type: Article

References (29)

1. Lewis HD, Davis JW, Archibald DG et al. Protective effects of aspirin against acute myocardial infarction and deaths in men with unstable angina. Results of a Veterans Administration Cooperative Study. N Engl J Med 1983;309:396-403.
2. Gurfinkel EP, Manos EJ, Mejait RI et al. Low molecular weight heparin versus regular heparin or aspirin in the treatment of unstable angina and silent ischemia. J Am Coll Cardiol 1995;26:313-8.
3. Chazov EI, Matueeva LS, Mazaev AV et al. Intracoronary administration of fibrinolysis in acute myocardial infarction. Ter Arrh 1976;48(4):8-19.
4. The EPIC Investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in High-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
5. Goodman SG, Cohen M, Bigonzi F et al. Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease. One-year results of the ESSENCE Study. J Am Coll Cardiol 2000;36:693-8.
6. Fragmin and fast revascularization during InStability in Coronary artery disease (FRISC II) Investigators. Long-term low molecular mass heparin in unstable coronary artery disease: FRISC II prospective randomized multicentre study. Lancet 1999;354:701-7.
7. Yusuf S, Flather M, Pogue J et al. for the OASIS (Organisation to Assess Strategies for Ischaemic Syndromes) Registry Investigators. Lancet 1998;352:507-14.
8. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 1997;96:4095-103.
9. Gurfinkel E, Leon de la Fuente RL, Mendiz O et al. Influenza vaccine pilot study in acute myocardial infarction and planned percutaneous coronary intervention. The Flu Vaccination Acute Coronary Syndromes (FLUVACS) Study Group. Circulation 2002;105:2143-8.
10. ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non-ST Segment Elevation Myocardial Infarction. A report of the American College of Cardiology /American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 2000;36:970-1062.
11. Advisory Committee on Immunization Practices (ACIP). Prevention and Control of Influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 2002;51(RR-3):1-36.
12. Antman EM, Cohen M, Bernink PJLM et al. The TIMI risk score for unstable angina/non-ST elevation myocardial infarction. A method for prognostication and therapeutic decision making. JAMA 2000;284:835-42.
13. Leon de la Fuente R, Gurfinkel E, Toledo D et al. Influenza vaccine pilot study in Acute Myocardial Infarction and Planned Percutaneous Coronary Interventions. The FLUVACS Study. Subgroup analysis. Rev Esp Cardiol 2003;56:949-54.
14. Woodhouse PR, Khaw KT, Plummer M et al. Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease. Lancet 1994;343(8895):435-9.
15. Tillet HE, Smith JWG, Gooch CD. Excess death attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol 1983;12(3):344-52.
16. The Eurowinter Group. Cold exposure and winter mortality from ischaemic heart disease, cerebrovascular disease, respiratory disease, and all causes in warm and cold regions of Europe. Lancet 1997;349:1341-3.
17. Siscovick DS, Raghunthan TE, Lin D et al. Influenza vaccination and the risk of primary cardiac arrest. Am J Epidemiol 2000;152:674-7.
18. Naghavi M, Barlas Z, Siadaty S et al. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation 2000;102:3039-45.
19. Lavallee P, Perchaud V, Gautier-Bertrand M et al. Association between influenza vaccination and reduced risk of brain infarction. Stroke 2002;33:513-8.
20. Nichol KL, Nordin J, Mullooly J et al. Influenza vaccination and reduction in hospitalisations for cardiac disease and stroke among the elderly. N Engl J Med 2003;348:1322-32.
21. Dimayuga P, Cercek B, Oguchi S et al. Inhibitory effect on arterial injury-induced neointimal formation by adoptive B-cell transfer in rag-1 knockout mice. Arterioscler Thromb Vasc Biol 2002;22:644-9.
22. Caligiuri G, Nicoletti A, Poirier B et al. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic. J Clin Invest 2002;109(6):721-4.
23. Visser MR, Tracy PB, Vercellotti GM et al. Enhanced thrombin generation and platelet binding on herpes simplex virus-infected endothelium. Proc Natl Acad Sci USA 1988;85(21):8227-30.
24. Etingin OR, Silverstein RL, Hajjar DP, von Willebrand factor mediates platelet adhesion to virally infected endothelial cells. Proc Natl Acad Sci USA 1993;90:5153-6.
25. Key NS, Vercellotti GM, Winkelmann JC et al. Infection of vascular endothelial cells with herpes simplex virus enhances tissue factor activity and reduces thrombomodulin expression. Proc Natl Acad Sci USA 1990;87(18):7095-9.
26. Van de Werf F, Topol EJ, Lee KL et al. Variations in patient management and outcomes for acute myocardial infarction in the United States and other countries: results from the GUSTO trial. JAMA 1995;273:1586-91.
27. Gurfinkel E, Bozovich G, Mautner B. International comparison of mortality rates in patients with non-ST elevation acute coronary events. Heart 2003;89:1083-4.
28. Zahn R, Schneider S, Frilling B et al. Antibiotic therapy after acute myocardial infarction: a prospective randomized study. Circulation 2003;107:1253-9.
29. Advisory Committee on Immunization Practices (ACIP). Prevention and control of influenza: recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1999;48(RR-4):1-28.